|4May 16, 5:19 PM ET

DOCHERTY JOHN MARTIN 4

4 · Lexaria Bioscience Corp. · Filed May 16, 2025

Insider Transaction Report

Form 4
Period: 2025-05-15
DOCHERTY JOHN MARTIN
DirectorPresident
Transactions
  • Award

    Stock Options

    2025-05-15+150,000310,834 total
    Exercise: $1.04From: 2025-05-15Exp: 2030-05-15Common Shares (150,000 underlying)
Holdings
  • common shares

    (indirect: Private Holding Company)
    54,075
  • Stock Options

    Exercise: $3.00From: 2021-04-26Exp: 2026-04-26Common Shares (18,000 underlying)
    18,000
  • Stock Options

    Exercise: $3.00From: 2021-06-08Exp: 2026-06-08Common Shares (18,334 underlying)
    36,334
  • Stock Options

    Exercise: $3.00From: 2021-09-01Exp: 2026-09-01Common Shares (15,000 underlying)
    51,334
  • Stock Options

    Exercise: $2.91From: 2022-08-29Exp: 2027-08-29Common Shares (30,000 underlying)
    81,334
  • Stock Options

    Exercise: $1.15From: 2023-10-26Exp: 2028-10-26Common Shares (30,000 underlying)
    111,334
  • Stock Options

    Exercise: $2.36From: 2024-04-26Exp: 2029-04-26Common Shares (49,500 underlying)
    160,834

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT